It received the final acceptance for use of Neutron Therapeutics’ accelerator, meaning the facility can now be used. The first-of-its-kind facility enables research into the effect of neutrons in a variety of fields. These include nuclear energy, nuclear science and boron neutron capture therapy (BNCT).
“The University of Birmingham’s neutron facility brings together a wide community of researchers in fields ranging from fundamental nuclear physics to nuclear materials to radiation oncology, and we are honoured to be part of this initiative,” said Noah Smick, president and COO of Neutron Therapeutics.
The UK’s first high-flux neutron test facility also come…